Carotuximab Biosimilar - Anti-ENG mAb - Research Grade
Source
CAS 1268714-50-6
Species
Chimeric
Expression system
Mammalian cells
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Carotuximab,TRC-105,c-SN6j,ENG,anti-ENG
Reference
PX-TA1421
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-kappa
Clonality
Monoclonal Antibody
Description of Carotuximab Biosimilar - Anti-ENG mAb - Research Grade
General information on Anti-ENG[Homo sapiens] (Carotuximab) Monoclonal Antibody
Carotuximab has been investigated for the treatment of Metastatic NSCLC, Recurrent Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, Advanced Soft Tissue Sarcoma, Hepatocellular Carcinoma, Glioblastoma, Glioblastoma Multiforme, Metastatic Breast Cancer and Advanced Angiosarcoma.
SDS-PAGE for Carotuximab Biosimilar - Anti-ENG mAb
Carotuximab Biosimilar - Anti-ENG mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Carotuximab Biosimilar – Anti-ENG mAb – Research Grade” Cancel reply
Related products
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Reviews
There are no reviews yet.